FDC Limited | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Development
Email & Communication
Keywords & Focus Areas
FDC Limited
Overview
FDC Limited is a prominent Indian pharmaceutical company with a history that dates back to 1936. Founded by Mr. Anand Chandavarkar, the company was established as FDC Limited in 1940 and began its manufacturing journey in 1949. The organization focuses on the development, manufacturing, and marketing of finished dosage forms and active pharmaceutical ingredients.
Recognized for its expertise in specialized formulations, the company leads the market in areas such as oral rehydration solutions, energy drinks, antibiotics, and ophthalmic therapies. One of its flagship products is Electral, a well-known oral rehydration salt. FDC operates multiple manufacturing plants, including a facility in Roha that produces a variety of pharmaceutical dosage forms and consumer healthcare products. With a significant global presence, the company maintains subsidiaries in the USA and the UK, and a joint venture in South Africa, serving healthcare professionals, hospitals, pharmacies, and consumers by emphasizing innovation, quality, and affordability in its diverse offerings.
Basic Information
| Industry | pharmaceuticals |
|---|---|
| Founded | 1936 |
| Revenue | 246.8M |
| Headquarters | 142-48, S. V. Road, Jogeshwari, Maharashtra, Mumbai, 400102, India |
| Languages | English |
| Parent Organization | FDC International FZCO |
Contact Details
- Phone: +91 22267 80652
- Website: fdcindia.com
- LinkedIn: linkedin.com/company/fdc-limited
Key Focus Areas & Initiatives
- Pharmaceutical manufacturing
- Consumer healthcare
- Oral rehydration solutions
- Energy drinks
- Antibiotics
- Anti-fungal medications
- Vitamins
- Minerals
- Specialized formulations
- Global reach
- Research and development
- Affordable healthcare
- Quality excellence
- Innovative drug delivery
- Active pharmaceutical ingredients
- Market share
- Healthcare professionals
- Domestic market
- International market
- Therapeutic segments
- Customer demographics
- Partnerships
- Functional foods
- Biotechnology
- Ophthalmics
- Nutritional support
- Healthcare accessibility
- Quality healthcare products
- Anti-infectives
- Gastrointestinal treatments
- Cardiovascular solutions
- Anti-diabetics
- Customer satisfaction
- Market leadership
- Stock performance
- Corporate governance
- Annual general meeting
- Eye drops
- Oral rehydration salts
- Electrolyte drinks
- Antibacterial
- Anti-fungal
- Haematinics
- Antiglucoma
- Anti-hypertensives
- Corticosteroids
- Infant formula
- APIs
- Drug delivery
- Clinical research
- Nutritional supplements
- Medications
- Electrolyte management
- Dextromethorphan
- Carboxymethyl cellulose
- Chloramphenicol
- Brimonidine
- Dorzolamide
- Timolol
- Moxifloxacin
- Gentamicin
- Salbutamol
- Amoxicillin
- Levocetirizine
- Tapentadol
- Sodium cromoglicate
- Vitamin supplements
- Anti-inflammatories
- Dexamethasone
- Ofloxacin
- Terbinafine
- Fluconazole
- Sodium hyaluronate
- Zinc sulfate
- Antihistamines
- Anti-virals
- Fentanyl
- Immunomodulators
- Nutraceuticals
- Evidence-based medicine
- B2B
- B2C
- Services
- Retail
- Medical
- Research & development
Technologies Used
- Apache
- Bootstrap Framework
- Gmail
- Google Apps
- Mobile Friendly
- S/4HANA
- Sendgrid
- Typekit
- reCAPTCHA